CNMD · Business segments
CONMED (CNMD) revenue by segment
Where CONMED’s revenue comes from, as reported in its SEC filings.
Latest quarter: September 30, 2026
Total revenue on the income statement: $335.6M.
Revenue by Geography
| Line | Revenue | Share |
|---|---|---|
| United States | $172.7M | 51.5% |
| EMEA | $67.6M | 20.2% |
| Asia Pacific | $60.4M | 18.0% |
| Americas (Excluding the United States) | $34.9M | 10.4% |
Revenue by Product
| Line | Revenue | Share |
|---|---|---|
| General Surgery | $186.7M | 55.6% |
| Orthopedic Surgery | $148.8M | 44.4% |
Latest year: December 31, 2025
Total revenue on the income statement: $1.37B.
Revenue by Geography
| Line | Revenue | Share |
|---|---|---|
| United States | $774.6M | 56.3% |
| EMEA | $264.7M | 19.3% |
| Asia Pacific | $208.7M | 15.2% |
| Americas (Excluding the United States) | $126.8M | 9.2% |
Revenue by Product
| Line | Revenue | Share |
|---|---|---|
| General Surgery | $800.1M | 58.2% |
| Orthopedic Surgery | $574.6M | 41.8% |
Reading notes
Share is each line’s part of that breakdown. Margin is the company’s reported segment operating income divided by that segment’s revenue. Companies define segment profit differently and may re-cut segments over time, so a company’s lines can differ between years. Breakdowns that do not add up to within 5% of reported revenue are left out.